-
Under Rs 2650 Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 10, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
No Comments
Five under Rs 2650 stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Affle 3i, Cholamandalam, Dr Lal, Happy Forgings and Ipca Labs.
-
Under Rs 2600 Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 6, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Five under Rs 2600 stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Ipca Labs, Coforge, Nilkamal, Phoenix and RR Kabel.
-
Fifty Percent Quarterly Profit Growth Stocks to Buy in November 2026: 5 Names on the Watchlist
- November 6, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Five fifty percent quarterly profit growth stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Patanjali Foods, Ipca Labs, ITC Hotels, Premier and Finolex Cables.
-
3 Pharma Excipients and Food Ingredients Maker, Pharmaceutical Company and Dairy Products Company Stocks With a Strong Future Roadmap: Sudeep Pharma, Ipca Laboratories and Dodla Dairy
- November 6, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Excipient, Pharma and Dairy Stocks with a strong future roadmap: Sudeep Pharma, Ipca Laboratories and Dodla Dairy. Compare price, valuation, return on equity and revenue growth as of 5 November 2026.
-
3 Child Hospitals Operator, Power Transmission Projects Builder and Pharma Company Stocks With a Strong Future Roadmap: Rainbow Children’s Medicare, Techno Electric & Engineering Company and Ipca Laboratories
- November 5, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Child Hospital, Grid Project and Drug Stocks with a strong future roadmap: Rainbow Children’s Medicare, Techno Electric & Engineering Company and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 4 November 2026.
-
3 Pathology and Diagnostics Network, Healthcare Technology and Services Company and Formulations and Ingredients Maker Stocks With a Strong Future Roadmap: Metropolis Healthcare, Indegene and Ipca Laboratories
- November 4, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Pathology, Health Tech and Drug Stocks with a strong future roadmap: Metropolis Healthcare, Indegene and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 3 November 2026.
-
3 Contract Development Company, Pain and Chronic Care Brand Owner and Active Ingredients Maker Stocks With a Strong Future Roadmap: Anthem Biosciences, Ipca Laboratories and Granules India
- October 28, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Development, Pain Brand and API Pharma with a strong future roadmap: Anthem Biosciences, Ipca Laboratories and Granules India. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 US Generics and Branded Medicines Company, Pain and Anti-Malarial Brands Leader and Soft Gel Capsules Producer Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Ipca Laboratories and Strides Pharma Science
- October 27, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
US Generics, Pain Care Brand and Soft Gel Stocks with a strong future roadmap: Alembic Pharmaceuticals, Ipca Laboratories and Strides Pharma Science. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Global Generics Leader, Specialty Branded Generics Seller and Pain and Anti-Malarial Brand Owner Stocks With a Strong Future Roadmap: Dr. Reddy’s Laboratories, Ajanta Pharma and Ipca Laboratories
- October 26, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Global Generic and Specialty Pharma Stocks with a strong future roadmap: Dr. Reddy’s Laboratories, Ajanta Pharma and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Pain and Anti-Malarial Brand Owner, Contract Formulations Maker and Branded Generics Exporter Stocks With a Strong Future Roadmap: Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals
- October 26, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Formulation and Branded Generic Pharma Stocks with a strong future roadmap: Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
- 1
- 2